XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue (Tables)
 3 Months Ended
Mar. 31, 2022
Revenue From Contract With Customer [Abstract]  
Schedule Of Collaboration Revenue Revenue was as follows for the three months ended March 31, 2022 and 2021:

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Neurocrine Biosciences:

 

 

 

 

 

 

 

 

    Recognition of the transaction price

 

$

372

 

 

$

—

 

    Research and development services

 

 

1,270

 

 

 

1,358

 

    Milestone payments

 

 

7,124

 

 

 

—

 

Pacira BioSciences:

 

 

 

 

 

 

 

 

   Milestone payments

 

 

—

 

 

 

3,000

 

Total collaboration revenue

 

$

8,766

 

 

$

4,358